It's time Ramaphosa takes decisive decisions on his advisors and political appointees, writes Mpumelelo Mkhabela.
Showers late. Mostly sunny. Mild.
Healthcare company Ascendis Health's share price dropped over 7% on Wednesday after it delayed the announcement of its annual results for the second time.
Through a Sens announcement, Ascendis announced that John A Bester retired from the board as chair and independent non-executive director and would be replaced by Andrew Marshall.
Ascendis Health has concluded a sale agreement of its pharmaceutical manufacturing facility in Isando to an international pharmaceutical company for R130m.
Ascendis Health says it is selling its non-core businesses as part of a strategy to boost profitability.
Health and care brands group Ascendis Health has reported a 27% increase in revenue to R4bn for the six months to December 2017.
Ascendis Health has reported growth in normalised headline earnings of 92% on increased international sales following the completion of acquisitions in Europe.
Ascendis Health wants to make its business a proper empire and follows a different approach to SA, Africa and Europe in order to reach this goal, says the CEO.
The strength of the business of Ascendis Health lies in its diversification from a customer point of view - and from a product point of view, it makes the business resilient.
Health and care brands company Ascendis Health has completed all conditions pertaining to the R7.3bn acquisitions of two European companies.
Ascendis Health is continuing its international growth strategy with the acquisition of two major European health and care businesses for a total of R7.3bn.
In a brief update to shareholders late on Thursday, the group's board said its CEO Thomas Thomsen's contract had been terminated.
South African-based international health and wellness business Ascendis Health [JSE:ASC] on Monday saw its share price drop by over 4% after reporting a 3% increase in revenue to R4bn for the six months to December 2018.
The JSE-listed health and wellness company announced a 35% increase in international revenue in its latest annual financial results.
Multinational health and care brands company Ascendis Health has become the first healthcare company to list on A2X Markets.
The proceeds of a rights offer by Ascendis Health will be used to settle €50m of the deferred vendor consideration payment owed to the sellers of Remedica Holdings.
Ascendis Health has finalised a number of European acquisitions in recent months which are expected to boost profit margins in 2018.
Global pharmaceutical company Cipla announced on Sunday that it has agreed to divest its 100% stake in Cipla Agrimed SA and Cipla Vet SA to Ascendis Health.
Ascendis Health has increased revenue by 39% to R3.9bn in the year to end-June 2016, with normalised headline earnings rising by 37% to R336m.
Ascendis Health says its R1.2bn rights issue, which closed last week, has been more than three times oversubscribed.
Cape TownHire ResolveR500 000.00 - R600 000.00 Per Year
MilnertonMotorelli Electric MotorsR14 000.00 - R16 000.00 Per Month
Western CapeTSM Consulting
R 15 500 000
R 6 100 000
R 5 525 000
We subscribe to the Press Code.
You choose what you want
News24 on Android
Get the latest from News24 on your Android device.
Terms and Conditions
24.com Terms and Conditions - Updated April 2012
Creating your profile will enable you to submit photos and stories to get published on News24.
This username must be unique, cannot be edited and will be used in the URL to your profile page across the entire 24.com network.